首页> 外国专利> PLASMID FOR PRODUCTION OF CRM PROTEIN AND DIPHTHERIA TOXIN, MICROORGANISM TRANSFORMED WITH SUCH PLASMID AND METHOD FOR PRODUCTION OF CRM PROTEIN AND DIPHTHERIA TOXIN USING SUCH PLASMID AND MICROORGANISM

PLASMID FOR PRODUCTION OF CRM PROTEIN AND DIPHTHERIA TOXIN, MICROORGANISM TRANSFORMED WITH SUCH PLASMID AND METHOD FOR PRODUCTION OF CRM PROTEIN AND DIPHTHERIA TOXIN USING SUCH PLASMID AND MICROORGANISM

机译:用于生产CRM蛋白质和白喉毒素的质粒,经这种质粒转化的微生物以及使用该质粒和微生物的CRM蛋白质和白喉毒素的生产方法

摘要

The invention pertains to a novel method and plasmid system for producing abundant quantities of CRM197 protein, diphtheria toxin or other CRM proteins related to diphtheria toxin, as well as to microorganisms transformed with the novel plasmid. A particularly preferred DNA plasmid, designated pPX 3511, that combines the gene for CRM197 from the nontoxigenic betaphage and the plasmid pNG2-22 is described. The novel plasmid system is capable of transforming strains of Corynebacterium diphtheriae into strains which are capable of expressing high levels of the CRM197 protein without the use of multiple lysogens. The invention provides in elegant means for increasing protein production without having to manipulate the expression vector, such as by increasing the promoter strength, or removing the promoter from iron regulation.
机译:本发明涉及用于产生大量CRM197蛋白,白喉毒素或其他与白喉毒素有关的CRM蛋白的新型方法和质粒系统,以及用该新型质粒转化的微生物。描述了一种特别优选的DNA质粒,称为pPX 3511,其结合了来自非毒性β噬菌体的CRM197的基因和质粒pNG2-22。该新型质粒系统能够将白喉棒状杆菌菌株转化为能够在不使用多种溶菌原的情况下表达高水平CRM197蛋白的菌株。本发明提供了一种优雅的手段,用于增加蛋白质产量而无需操纵表达载体,例如通过增加启动子强度或从铁调节中去除启动子。

著录项

  • 公开/公告号IL108822A

    专利类型

  • 公开/公告日2004-09-27

    原文格式PDF

  • 申请/专利权人 WYETH HOLDINGS CORPORATION;

    申请/专利号IL19940108822

  • 发明设计人

    申请日1994-03-02

  • 分类号C12N15/77;C12N15/31;C12N1/21;C07K14/34;

  • 国家 IL

  • 入库时间 2022-08-21 23:10:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号